CoChat

Role of gut microbiota in functional constipation

Open access
Zhang, Shengsheng, Wang, Ruixin, Li, Danyan, Zhao, Luqing, Zhu, Lixin · 2021 · Gastroenterology Report

The DOI matches its Crossref record; 102 of the 108 references it cites were found in a registry or an index; 6 of the 64 sources its claims cite were checked for support.

Abstract

Functional constipation (FC) is common, yet the etiology is not clear. Accumulating evidence suggests an association between FC and abnormal gut microbiota. The relationship between the gut microbiota and the gut transit is likely bidirectional. This review summarizes the current evidence regarding the impact of gut microbiota on the pathogenesis of FC. By modulating the colonic motility, secretion, and absorption, gut microbiota may contribute to the development of FC through microbial metabolic activities involving bile acids, short-chain fatty acids, 5-hydroxytryptamine, and methane. In support of the key roles of the gut microbiota in FC, treatment with probiotics, prebiotics, synbiotics, and traditional Chinese medicine often result in compositional and functional changes in the gut microbiota. Further studies on the pathogenesis of FC and the therapeutic mechanism of microecological agents will provide a knowledge base for better management of FC.

Overview

CoChat Summary

TL;DR

This review argues that gut microbiota dysbiosis is an important feature of functional constipation (FC) and may contribute to FC through microbial metabolites including bile acids, short-chain fatty acids, 5-HT, and methane. It also summarizes evidence that probiotics, prebiotics, synbiotics, and traditional Chinese medicine can improve FC partly by changing gut microbiota.

Key findings

  • In a demographic survey of 6,300 cases from three countries, FC prevalence by Rome IV criteria was 6.9% in the USA, 7.9% in Canada, and 8.6% in the UK; a global estimate from 1947–2010 was 14%.
  • The paper reports inconsistent microbiota profiles across studies: in adolescent FC, Prevotella decreased and Coprococcus, Ruminococcus, Blautia, Anaerotruncus, and Clostridium increased; in adult FC, other studies found decreased Bifidobacterium/Lactobacillus or depletion of Bacteroides, Roseburia, and Coprococcus 3.
  • For microbial metabolites, the review states that FC stool studies found fecal acetate 2.2-fold higher than controls, and that acetate, butyrate, and propionate were associated with transit time; it also notes reports of elevated SCFAs and methanogenic bacteria enrichment in FC, but says evidence is inconsistent.
  • Intervention evidence summarized in the review suggests probiotics can improve whole-gut transit time, stool frequency, stool consistency, and bloating in meta-analyses, while one double-blind trial found no primary difference vs placebo but a post hoc benefit for B. animalis subsp. lactis HN019 on spontaneous defecation frequency and straining.

Methods

  • Narrative review of the literature on gut microbiota and functional constipation, with emphasis on human observational studies, animal studies, and intervention trials.
  • The paper compares findings from culture-based studies, qPCR, 16S rRNA sequencing, and whole-genome sequencing studies, and also summarizes randomized trials and meta-analyses of microbiota-targeted therapies.
  • The review’s main analysis is mechanistic synthesis, organizing evidence around bile acids, SCFAs, 5-HT, methane, and microbiota-directed treatments.

Limitations

  • The paper states that there is no consensus on the gut microbial structure characteristic of FC, and that inconsistent findings may reflect cultural and demographical differences, different analysis techniques, and possible evolution of disease over time.
  • It explicitly warns that several mechanistic findings from mouse studies remain to be validated in humans, and that the very different diet and gut microbiota of laboratory animals vs humans limit translation.
  • Evident from the text: many intervention and mechanistic studies are described as having small sample sizes, and the review repeatedly notes that several proposed mechanisms and treatments still need adequately powered clinical trials.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/gastro/goab035

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Diagnosis of functional constipation according to the Rome IV criteria.
Figure 1. Diagnosis of functional constipation according to the Rome IV criteria.CC BY · PubMed Central
Figure 2. Potential molecular mechanisms for the gut microbiota that contribute to the pathogenesis of functional constipation (FC). (1) Bile acids (BAs) stimulate bowel movement and colonic secretion and suppress colonic absorption. The gut microbiota impacts these processes by regulating the BA levels, as well as the sulfation of BAs, which abolishes the effects of BAs on colonic transit. (2) Elevated levels of short-chain fatty acids (SCFAs), the major group of microbial fermentation products, stimulate electrolyte absorption and suppress mucin secretion, thus contributing to the pathogenesis of FC. The effect of SCFA on colonic motility is a controversial topic. (3) 5-hydroxytryptamine (5-HT) stimulates colonic motility. The gut microbiota regulates the level of 5-HT through several mechanisms and thereby affects the pathogenesis of FC. (4) Methane produced by the gut microbiota reduces bowel movement. 5-HTP, 5-hydroxytryptophan.
Figure 2. Potential molecular mechanisms for the gut microbiota that contribute to the pathogenesis of functional constipation (FC). (1) Bile acids (BAs) stimulate bowel movement and colonic secretion and suppress colonic absorption. The gut microbiota impacts these processes by regulating the BA levels, as well as the sulfation of BAs, which abolishes the effects of BAs on colonic transit. (2) Elevated levels of short-chain fatty acids (SCFAs), the major group of microbial fermentation products, stimulate electrolyte absorption and suppress mucin secretion, thus contributing to the pathogenesis of FC. The effect of SCFA on colonic motility is a controversial topic. (3) 5-hydroxytryptamine (5-HT) stimulates colonic motility. The gut microbiota regulates the level of 5-HT through several mechanisms and thereby affects the pathogenesis of FC. (4) Methane produced by the gut microbiota reduces bowel movement. 5-HTP, 5-hydroxytryptophan.CC BY · PubMed Central

Verification

Claims the paper makes

5 Valid · 1 Not valid · 38 Not checked · 18 Own results and interpretations

21 more claims

Create a free account to see all 62 claims and to verify the 58 references still open.

See all claims — free account
  • It may state two separate claims as one. 27
  • Probably not a substantial claim. 14
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 102 references

Research works printed but not linked: 2

  1. Zhang, 2017, Expert consensus on TCM diagnosis and treatment of constipation, Zhong Yi Za Zhi, 58, 1345
  2. Yang, 2007, Progress in traditional Chinese medicine treatment of chronic functional constipation, Bei Jing Zhong Yi, 26, 61

Cited by

See all 175

Metadata

Authors
Zhang, S., Wang, R., Li, D., Zhao, L., & Zhu, L.
Affiliations
  • Capital Medical University (CN)
  • Sixth Affiliated Hospital of Sun Yat-sen University (CN)
Corresponding author
  • Zhao, Luqing
  • Zhu, Lixin
Venue
Gastroenterology Report
Published
2021-08-06
Volume
9
Issue
5
Pages
392-401
ISSN
2052-0034 (ISSN-L)
OpenAlex
W3190212528
Cited by
175
References
108
Citations by year
2026: 37 · 2025: 35 · 2024: 45 · 2023: 41 · 2022: 17
FWCI
4.91
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology report (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Clinical Medicine Development Project of Beijing Municipal Administration of Hospitals (ZYLX201411)
  • Beijing Nova Program (Z201100006820119)
  • Beijing Municipal Science & Technology Commission
  • Beijing Science and technology (z181100001718218)
  • National Natural Science Foundation of China (81770571)
  • Guangdong Province ‘Pearl River Talent Plan’ Innovation and Entrepreneurship Team Project (2019ZT08Y464)
  • National Key Clinical Discipline of China
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
functional constipation, gut microbiota, colonic motility, gastrointestinal transit, bile acids, short-chain fatty acids, serotonin, methane, probiotics, prebiotics, synbiotics, traditional Chinese medicine, pathogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of gut microbiota in functional constipation. https://app.cochat.ai/papers/10.1093/gastro/goab035
The paper
Zhang, S., Wang, R., Li, D., Zhao, L., & Zhu, L. (2021). Role of gut microbiota in functional constipation. Gastroenterology Report. https://doi.org/10.1093/gastro/goab035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.